Compare ICICI Bank Limited Common Stock (IBN) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ICICI Bank Limited Common Stock vs Immunovant Inc. Common Stock — how do they compare? ICICI Bank Limited Common Stock trades at $28 (market cap $101.12B), while Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B). The key difference: ICICI Bank Limited Common Stock is far larger — about 15.3× Immunovant Inc. Common Stock's market cap, and ICICI Bank Limited Common Stock pays a 0.9% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ICICI Bank Limited Common Stock for 0 Days and Immunovant Inc. Common Stock for 0 Days on average.
| IBN | IMVT | |
|---|---|---|
Market Cap | $101.12B | $6.62B |
Volume | 4,164,148 | 1,131,364 |
Sector | Financials | Health |
52-Week High | $32.94 | $44.96 |
52-Week Low | $25.20 | $17.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $9.97T | $5.72B |
Dividend Yield | 0.9% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ICICI Bank Limited Common Stock
ICICI Bank is an Indian financial services company providing banking, lending, cards, insurance, and investment products. It serves retail, business, and corporate customers.
Read more on IBN →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
